Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04482920 · ClinicalTrials.gov registry record
Effect of Hormone Therapy on Renal Function
A clinical trial of Kidney Diseases and Kidney Injury, sponsored by University of Colorado, Denver.
- Completed
- Registry status
- 22
- Enrollment target
- 1
- Study location
NCT04482920 is a study of Kidney Diseases and Kidney Injury that has completed, run by University of Colorado, Denver. The registered enrollment target is 22 participants, below the 1,785-participant average among 38 other Kidney Diseases trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04482920, a study of Kidney Diseases and Kidney Injury, has completed, sponsored by University of Colorado, Denver.
- COMPLETED
- Registry status
- 22 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to understand the effects of testosterone or estradiol on kidney function in transgender adolescents and young adults.
Conditions Studied
Interventions
- DIAGNOSTIC_TEST p-aminohippurate clearance study
- DIAGNOSTIC_TEST Iohexol infusion
Study Locations (1)
Colorado
- Children's Hospital Colorado - Aurora
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 22 participants |
| Start Date | 2021-04-15 |
| Est. Completion | 2023-08-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04482920
The ClinicalTrials.gov registry entry for NCT04482920 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 22 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,785-participant average among 38 other Kidney Diseases trials with a reported enrollment target (99% lower). The listed sponsor is University of Colorado, Denver, which has 1,283 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Kidney Diseases appearing as the primary indexed condition, and to 2 interventions - of which p-aminohippurate clearance study is the first listed.
NCT04482920 reports 1 study location spanning 1 distinct geographic area - top geographies include Colorado.
Frequently Asked Questions
What is clinical trial NCT04482920 about?
NCT04482920 is a clinical study titled "Effect of Hormone Therapy on Renal Function". The purpose of this study is to understand the effects of testosterone or estradiol on kidney function in transgender adolescents and young adults.
What is the current status of trial NCT04482920?
This trial is currently completed. The enrollment target is 22 participants. The study started on 2021-04-15. Estimated completion is 2023-08-31.
What conditions does trial NCT04482920 study?
This clinical trial studies the following conditions: Kidney Diseases, Kidney Injury, Transgenderism.
What interventions are being tested in trial NCT04482920?
The interventions under investigation include: p-aminohippurate clearance study (DIAGNOSTIC_TEST), Iohexol infusion (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT04482920?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04482920 being conducted?
This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Kidney Diseases
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Collaborative Learning to Achieve Refined Interventions for Emory: Kidney Disease
RECRUITING · NA
-
Rutgers University Study of the Genetics of Kidney Disease
RECRUITING
-
Supporting VETerans With Kidney Disease Through Food As Medicine
RECRUITING · NA
-
Kidney Transplant Preemptive Therapy or Prophylaxis for CMV Prevention in D+R Recipients
RECRUITING · Phase 3
-
Methocarbamol vs Oxybutynin for Management of Pain and Discomfort S/P Ureteroscopy Procedure
RECRUITING · NA
-
Dietary Intervention to Improve Kidney Transplant Outcomes
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.